These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 8852830)
1. Binding specificity of medroxyprogesterone acetate and proligestone for the progesterone and glucocorticoid receptor in the dog. Selman PJ; Wolfswinkel J; Mol JA Steroids; 1996 Mar; 61(3):133-7. PubMed ID: 8852830 [TBL] [Abstract][Full Text] [Related]
2. Effects of progestin administration on the hypothalamic-pituitary-adrenal axis and glucose homeostasis in dogs. Selman PJ; Mol JA; Rutteman GR; van Garderen E; van den Ingh TS; Rijnberk A J Reprod Fertil Suppl; 1997; 51():345-54. PubMed ID: 9404305 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the histological changes in the dog after treatment with the progestins medroxyprogesterone acetate and proligestone. Selman PJ; van Garderen E; Mol JA; van den Ingh TS Vet Q; 1995 Dec; 17(4):128-33. PubMed ID: 8751273 [TBL] [Abstract][Full Text] [Related]
4. Medroxyprogesterone acetate binds the glucocorticoid receptor to stimulate alpha-ENaC and sgk1 expression in renal collecting duct epithelia. Thomas CP; Liu KZ; Vats HS Am J Physiol Renal Physiol; 2006 Feb; 290(2):F306-12. PubMed ID: 16189295 [TBL] [Abstract][Full Text] [Related]
5. In vitro characterization of trimegestone: a new potent and selective progestin. Zhang Z; Lundeen SG; Zhu Y; Carver JM; Winneker RC Steroids; 2000; 65(10-11):637-43. PubMed ID: 11108870 [TBL] [Abstract][Full Text] [Related]
6. Progestin treatment in the dog. II. Effects on the hypothalamic-pituitary-adrenocortical axis. Selman PJ; Mol JA; Rutteman GR; Rijnberk A Eur J Endocrinol; 1994 Oct; 131(4):422-30. PubMed ID: 7921232 [TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid receptor activity discriminates between progesterone and medroxyprogesterone acetate effects in breast cells. Courtin A; Communal L; Vilasco M; Cimino D; Mourra N; de Bortoli M; Taverna D; Faussat AM; Chaouat M; Forgez P; Gompel A Breast Cancer Res Treat; 2012 Jan; 131(1):49-63. PubMed ID: 21336598 [TBL] [Abstract][Full Text] [Related]
8. The progestin-only contraceptive medroxyprogesterone acetate, but not norethisterone acetate, enhances HIV-1 Vpr-mediated apoptosis in human CD4+ T cells through the glucocorticoid receptor. Tomasicchio M; Avenant C; Du Toit A; Ray RM; Hapgood JP PLoS One; 2013; 8(5):e62895. PubMed ID: 23658782 [TBL] [Abstract][Full Text] [Related]
9. Anti-proliferative transcriptional effects of medroxyprogesterone acetate in estrogen receptor positive breast cancer cells are predominantly mediated by the progesterone receptor. Moore NL; Hanson AR; Ebrahimie E; Hickey TE; Tilley WD J Steroid Biochem Mol Biol; 2020 May; 199():105548. PubMed ID: 31805393 [TBL] [Abstract][Full Text] [Related]
10. Regulation of epidermal growth factor receptor by progestins and glucocorticoids in human breast cancer cell lines. Ewing TM; Murphy LJ; Ng ML; Pang GY; Lee CS; Watts CK; Sutherland RL Int J Cancer; 1989 Oct; 44(4):744-52. PubMed ID: 2793247 [TBL] [Abstract][Full Text] [Related]
11. Binding of progestins to the glucocorticoid receptor. Correlation to their glucocorticoid-like effects on in vitro functions of human mononuclear leukocytes. Kontula K; Paavonen T; Luukkainen T; Andersson LC Biochem Pharmacol; 1983 May; 32(9):1511-8. PubMed ID: 6222739 [TBL] [Abstract][Full Text] [Related]
12. Mechanism of cortisol/progesterone antagonism in the regulation of 15-hydroxyprostaglandin dehydrogenase activity and messenger ribonucleic acid levels in human chorion and placental trophoblast cells at term. Patel FA; Funder JW; Challis JR J Clin Endocrinol Metab; 2003 Jun; 88(6):2922-33. PubMed ID: 12788907 [TBL] [Abstract][Full Text] [Related]
13. Medroxyprogesterone acetate: receptor binding and correlated effects on steroidogenesis in rat granulosa cells. Pridjian G; Schmit V; Schreiber J J Steroid Biochem; 1987 Mar; 26(3):313-9. PubMed ID: 2953940 [TBL] [Abstract][Full Text] [Related]
14. Binding characteristics of mineralocorticoid and glucocorticoid receptors in dog brain and pituitary. Reul JM; de Kloet ER; van Sluijs FJ; Rijnberk A; Rothuizen J Endocrinology; 1990 Aug; 127(2):907-15. PubMed ID: 2164924 [TBL] [Abstract][Full Text] [Related]
15. A potential mechanism in medroxyprogesterone acetate teratogenesis. Kimmel GL; Hartwell BS; Andrew FD Teratology; 1979 Apr; 19(2):171-6. PubMed ID: 473071 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological effect of halogen substituted phenyl acetic acid derivatives of progesterone as potent progesterone receptor antagonists. Cabeza M; Bratoeff E; Gómez G; Heuze I; Rojas A; Ochoa M; Palomino MA; Revilla C J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):232-9. PubMed ID: 18625316 [TBL] [Abstract][Full Text] [Related]
17. Progestin treatment in the dog. I. Effects on growth hormone, insulin-like growth factor I and glucose homeostasis. Selman PJ; Mol JA; Rutteman GR; Rijnberk A Eur J Endocrinol; 1994 Oct; 131(4):413-21. PubMed ID: 7921231 [TBL] [Abstract][Full Text] [Related]
18. Chick oviduct glucocorticosteroid receptor. Specific binding of the synthetic steroid RU 486 and immunological studies with antibodies to chick oviduct progesterone receptor. Groyer A; Le Bouc Y; Joab I; Radanyi C; Renoir JM; Robel P; Baulieu EE Eur J Biochem; 1985 Jun; 149(2):445-51. PubMed ID: 3996417 [TBL] [Abstract][Full Text] [Related]
19. The injectable-only contraceptive medroxyprogesterone acetate, unlike norethisterone acetate and progesterone, regulates inflammatory genes in endocervical cells via the glucocorticoid receptor. Govender Y; Avenant C; Verhoog NJ; Ray RM; Grantham NJ; Africander D; Hapgood JP PLoS One; 2014; 9(5):e96497. PubMed ID: 24840644 [TBL] [Abstract][Full Text] [Related]
20. The relationship between affinity of progestins and antiprogestins for the progesterone receptor in breast cancer cells (ZR-PR-LT) and ability to down-regulate the receptor: evidence for heterospecific receptor modulation via the glucocorticoid receptor. van den Berg HW; Lynch M; Martin JH Eur J Cancer; 1993; 29A(12):1771-5. PubMed ID: 8398308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]